Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
Phase 2
Completed
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-11-19
- Last Posted Date
- 2010-03-04
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 132
- Registration Number
- NCT00794144
- Locations
- 🇺🇸
Niran Amar, M.D., Waco, Texas, United States
Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis
Phase 4
Completed
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- Other: Olopatadine nasal spray vehicle, pH 3.7Other: Olopatadine nasal spray vehicle, pH 7.0
- First Posted Date
- 2008-11-13
- Last Posted Date
- 2018-02-08
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1260
- Registration Number
- NCT00789555
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Terminated
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2008-11-11
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 197
- Registration Number
- NCT00788541
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
Phase 2
Completed
- Conditions
- Macular Edema
- Interventions
- Other: Nepafenac ophthalmic suspension vehicle
- First Posted Date
- 2008-10-31
- Last Posted Date
- 2012-10-26
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 263
- Registration Number
- NCT00782717
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 102
- Registration Number
- NCT00772304
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: Multi-Purpose Disinfecting Solution (OPTI-FREE RepleniSH)Device: Contact Lenses
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2012-09-07
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 114
- Registration Number
- NCT00772707
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
A 2-week Clinical Comparison of SYSTANE® Ultra to Sensitive Eyes Rewetting Drops in Contact Lens Wearing Patients.
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Systane UltraOther: Sensitive Eyes Rewetting Drops
- First Posted Date
- 2008-10-09
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 47
- Registration Number
- NCT00769665
Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green
Completed
- Conditions
- Conjunctival Staining
- Interventions
- Other: 2.5/5.0/10.0 µL lissamine green
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2012-04-13
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 30
- Registration Number
- NCT00768898
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
Phase 3
Terminated
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2012-09-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 17
- Registration Number
- NCT00767494
1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
Phase 3
Terminated
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2008-10-07
- Last Posted Date
- 2012-07-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 6
- Registration Number
- NCT00767481
© Copyright 2025. All Rights Reserved by MedPath